Evidence map›Paper›PMID 32597303›Full record

ArticleRNA biology2020

Targeted RNA sequencing enhances gene expression profiling of ultra-low input samples.

Fabiola Curion, Adam E Handel, Moustafa Attar, Giuseppe Gallone, Rory Bowden, M Zameel Cader, Michael B Clark

Registry-linked trialAbstract read
In one paragraph

Article in RNA biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05157581 (Open Label, Single-cohort, and Multi-center Phase II Study Evaluating Tumor-specific Immunity After Extracorporeal Photopheresis in Patients With Sézary Syndrome at Single-cell Resolution), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05157581 recruitingnot on this mapstarted 2023, after this paper: background citation

Open Label, Single-cohort, and Multi-center Phase II Study Evaluating Tumor-specific Immunity After Extracorporeal Photopheresis in Patients With Sézary Syndrome at Single-cell Resolution

TypeobservationalSponsorOleg E. Akilov, MD, PhDRan2023 to 2028Enrolled20ConditionsSezary SyndromeArmsExtracorporeal photopheresis (ECP), Methoxsalen Injection
3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cancers · 2025
    Article
  6. Review
  7. From DNA to Big Data: NGS Technologies and Their Applications.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fabiola CurionWellcome Centre for Human Genetics, University of Oxford , Oxford, UK.ORCID 0000-0003-2502-8803
Adam E HandelNuffield Department of Clinical Neurosciences, University of Oxford , Oxford, UK.ORCID 0000-0001-8385-6346
Moustafa AttarWellcome Centre for Human Genetics, University of Oxford , Oxford, UK.ORCID 0000-0003-4116-1276
Giuseppe GalloneDepartment of Physiology, Anatomy, and Genetics, University of Oxford , Oxford, UK.ORCID 0000-0001-6806-7226
Rory BowdenWellcome Centre for Human Genetics, University of Oxford , Oxford, UK.ORCID 0000-0001-8596-0366
M Zameel CaderNuffield Department of Clinical Neurosciences, University of Oxford , Oxford, UK.ORCID 0000-0002-6952-406X
Michael B ClarkDepartment of Psychiatry, University of Oxford , Oxford, UK.ORCID 0000-0002-2903-9537

Funding

Medical Research Council MC_PC_16034Wellcome TrustWellcome Trust 090532/Z/09/ZWellcome Trust 203141/Z/16/Z
6 · The paper itself

Abstract

RNA-seq is the standard method for profiling gene expression in many biological systems. Due to the wide dynamic range and complex nature of the transcriptome, RNA-seq provides an incomplete characterization, especially of lowly expressed genes and transcripts. Targeted RNA sequencing (RNA CaptureSeq) focuses sequencing on genes of interest, providing exquisite sensitivity for transcript detection and quantification. However, uses of CaptureSeq have focused on bulk samples and its performance on very small populations of cells is unknown. Here we show CaptureSeq greatly enhances transcriptomic profiling of target genes in ultra-low-input samples and provides equivalent performance to that on bulk samples. We validate the performance of CaptureSeq using multiple probe sets on samples of iPSC-derived cortical neurons. We demonstrate up to 275-fold enrichment for target genes, the detection of 10% additional genes and a greater than 5-fold increase in identified gene isoforms. Analysis of spike-in controls demonstrated CaptureSeq improved both detection sensitivity and expression quantification. Comparison to the CORTECON database of cerebral cortex development revealed CaptureSeq enhanced the identification of sample differentiation stage. CaptureSeq provides sensitive, reliable and quantitative expression measurements on hundreds-to-thousands of target genes from ultra-low-input samples and has the potential to greatly enhance transcriptomic profiling when samples are limiting.

Indexed as

Gene Expression ProfilingHigh-Throughput Nucleotide SequencingSequence Analysis, RNATranscriptomeCell DifferentiationComputational BiologyHumansNeuronsTranscription FactorsTranscription FactorsCaptureSeqgene expressionlow-input sequencingmethodRNA-seqstem-cell-derived neuronstargeted RNA sequencing

Identifiers

PMID32597303
PMCPMC7746246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.